Financiën AbbVie Inc.

Aandelen

ABBV

US00287Y1091

Farmaceutische producten

Geschatte realtime Cboe BZX Andere beurzen 19:02:28 16-01-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
214,66 ^USD	-0,17%		-2,09%	-5,69%

14/01	AbbVie wil zijn aanwezigheid op de obesitasmarkt uitbreiden	RE
14/01	AbbVie Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 08:15 AM

Voorlopige winst- en verliesrekening: AbbVie Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Omzet ¹	45.784	56.122	58.054	54.318	56.334	60.933	66.717	71.902
Variatie	-	22,58%	3,44%	-6,44%	3,71%	8,16%	9,49%	7,77%
EBITDA ¹	22.642	29.018	30.961	25.545	24.104	25.403	33.397	36.559
Variatie	-	28,16%	6,7%	-17,49%	-5,64%	5,39%	31,47%	9,47%
Bedrijfsresultaat (EBIT) ¹	21.976	28.215	30.183	24.793	23.340	24.724	32.397	35.841
Variatie	-	28,39%	6,98%	-17,86%	-5,86%	5,93%	31,04%	10,63%
Betaalde rente ¹	-2.280	-2.384	-2.044	-1.684	-2.160	-2.619	-2.277	-2.151
Resultaat voor belastingen (EBT) ¹	3.398	12.989	13.477	6.250	3.716	11.023	20.904	24.188
Variatie	-	282,25%	3,76%	-53,62%	-40,54%	196,64%	89,64%	15,71%
Nettowinst (verlies) ¹	4.616	11.542	11.836	4.863	4.278	5.529	17.441	20.373
Variatie	-	150,04%	2,55%	-58,91%	-12,03%	29,24%	215,45%	16,81%
Datum van publicatie	3/02/21	2/02/22	9/02/23	2/02/24	31/01/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Fiscaal tijdperk: december	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Omzet ¹	13.858	12.935	13.959	14.342	14.886	13.538	14.583	14.812	15.121	12.225	13.865	13.927	14.301	12.310	14.462	14.460	15.102	13.343	15.423	15.776	16.405	14.798	16.603	17.139	18.093
Variatie	-	-6,66%	7,92%	2,74%	3,79%	-9,06%	7,72%	1,57%	2,09%	-19,15%	13,42%	0,45%	2,69%	-13,92%	17,48%	-0,01%	4,44%	-11,65%	15,59%	2,29%	3,99%	-9,79%	12,19%	3,23%	5,56%
EBITDA ¹	6.722	6.808	7.145	7.559	7.506	7.156	7.643	8.090	8.072	5.682	6.710	6.706	6.447	5.378	6.342	6.937	5.447	5.829	7.019	5.073	7.725	-	-	-	-
Variatie	-	1,28%	4,95%	5,79%	-0,7%	-4,66%	6,81%	5,85%	-0,22%	-29,61%	18,09%	-0,06%	-3,86%	-16,58%	17,92%	9,38%	-21,48%	7,01%	20,42%	-27,72%	52,28%	-	-	-	-
Bedrijfsresultaat (EBIT) ¹	6.495	6.602	6.944	7.336	7.333	6.958	7.440	7.909	7.876	5.503	6.520	6.510	6.260	5.195	6.158	6.746	5.241	5.648	6.833	4.881	7.506	7.012	8.184	8.500	8.736
Variatie	-	1,65%	5,18%	5,65%	-0,04%	-5,11%	6,93%	6,3%	-0,42%	-30,13%	18,48%	-0,15%	-3,84%	-17,01%	18,54%	9,55%	-22,31%	7,77%	20,98%	-28,57%	53,79%	-6,58%	16,71%	3,86%	2,78%
Charge d'intérêts ¹	-618	-622	-606	-585	-571	-539	-532	-497	-476	-454	-454	-398	-378	-453	-506	-591	-610	-627	-678	-667	-649,9	-582,8	-583,8	-581,2	-576,8
Resultaat voor belastingen (EBT) ¹	-	-	-	-	-	-	-	-	-	475	2.610	1.953	1.212	1.755	2.146	2.084	-2.269	1.661	1.554	714	4.501	-	-	-	-
Variatie	-	-	-	-	-	-	-	-	-	-	449,47%	-25,17%	-37,94%	44,8%	22,28%	-2,89%	-208,88%	173,2%	-6,44%	-54,05%	530,39%	-	-	-	-
Nettowinst (verlies) ¹	36	3.553	766	3.179	4.044	4.490	924	3.949	2.473	239	2.024	1.778	822	1.369	1.370	1.561	-22	1.286	938	186	4.296	3.098	4.368	4.451	4.914
Variatie	-	9.769,44%	-78,44%	315,01%	27,21%	11,03%	-79,42%	327,38%	-37,38%	-90,34%	746,86%	-12,15%	-53,77%	66,55%	0,07%	13,94%	-101,41%	5.945,45%	-27,06%	-80,17%	2.209,95%	-27,89%	40,97%	1,92%	10,39%
Datum van publicatie	3/02/21	30/04/21	30/07/21	29/10/21	2/02/22	29/04/22	29/07/22	28/10/22	9/02/23	27/04/23	27/07/23	27/10/23	2/02/24	26/04/24	25/07/24	30/10/24	31/01/25	25/04/25	31/07/25	31/10/25	-	-	-	-	-

¹USD in Miljoen

Geschatte gegevens

Balansprognose: AbbVie Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Nettoschuld ¹	77.607	66.854	54.042	46.571	61.589	56.061	46.662	34.673
Variatie	-	-13,86%	-19,16%	-13,82%	32,25%	-8,98%	-16,77%	-25,69%
Datum van publicatie	3/02/21	2/02/22	9/02/23	2/02/24	31/01/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte kasstroom: AbbVie Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	798	787	695	777	974	1.099	1.223	1.283
Variatie	-	-1,38%	-11,69%	11,8%	25,35%	12,82%	11,25%	4,93%
Vrije kasstroom (FCF) ¹	16.790	21.990	24.248	22.062	17.832	18.235	25.948	27.935
Variatie	-	30,97%	10,27%	-9,02%	-19,17%	2,26%	42,3%	7,66%
Datum van publicatie	3/02/21	2/02/22	9/02/23	2/02/24	31/01/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte financiële ratio's: AbbVie Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Winstgevendheid
EBITDA-marge (%)	49,45%	51,71%	53,33%	47,03%	42,79%	41,69%	50,06%	50,85%
EBIT-marge (%)	48%	50,27%	51,99%	45,64%	41,43%	40,58%	48,56%	49,85%
EBT-marge (%)	7,42%	23,14%	23,21%	11,51%	6,6%	18,09%	31,33%	33,64%
Nettomarge (%)	10,08%	20,57%	20,39%	8,95%	7,59%	9,07%	26,14%	28,33%
FCF-marge (%)	36,67%	39,18%	41,77%	40,62%	31,65%	29,93%	38,89%	38,85%
Vrije kasstroom/nettoresultaat (%)	363,73%	190,52%	204,87%	453,67%	416,83%	329,81%	148,77%	137,12%
Winstgevendheid
ROA	3,85%	15,28%	17,24%	14,46%	13,34%	11,73%	15,54%	16,92%
ROE	188,25%	159,36%	150,62%	143,18%	263,08%	490,23%	376,28%	372,77%
Financiële gezondheid
Hefboom (schuld/ebitda)	3,43x	2,3x	1,75x	1,82x	2,56x	2,21x	1,4x	0,95x
Schuld/vrije kasstroom	4,62x	3,04x	2,23x	2,11x	3,45x	3,07x	1,8x	1,24x
Kapitaalintensiteit
Kapitaaluitgaven/omzet (%)	1,74%	1,4%	1,2%	1,43%	1,73%	1,8%	1,83%	1,78%
CAPEX / EBITDA (%)	3,52%	2,71%	2,24%	3,04%	4,04%	4,33%	3,66%	3,51%
CAPEX / FCF (%)	4,75%	3,58%	2,87%	3,52%	5,46%	6,03%	4,71%	4,59%
Bestanddelen per aandeel
Kasstroom per aandeel ¹	10,51	12,82	14,03	12,88	10,61	11,26	14,18	17,09
Variatie	-	21,92%	9,45%	-8,18%	-17,66%	6,13%	26%	20,52%
Dividend per aandeel ¹	4,84	5,31	5,71	5,99	6,29	6,543	6,821	7,136
Variatie	-	9,71%	7,53%	4,9%	5,01%	4,02%	4,25%	4,63%
Nettoactief per aandeel ¹	7,828	8,713	9,743	5,843	1,875	0,3158	2,923	6,736
Variatie	-	11,3%	11,82%	-40,03%	-67,9%	-83,16%	825,38%	130,46%
WPA ¹	2,72	6,45	6,63	2,72	2,39	2,951	10,06	11,61
Variatie	-	137,13%	2,79%	-58,97%	-12,13%	23,47%	240,91%	15,36%
Aantal aandelen (in duizend)	1.765.474	1.767.880	1.767.880	1.765.537	1.767.140	1.767.385	1.767.385	1.767.385
Datum van publicatie	3/02/21	2/02/22	9/02/23	2/02/24	31/01/25	-	-	-